N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer

The main protease (M(pro), also known as 3CL protease) of SARS-CoV-2 is a high priority drug target in the development of antivirals to combat COVID-19 infections. A feline coronavirus antiviral drug, GC376, has been shown to be effective in inhibiting the SARS-CoV-2 main protease and live virus gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Arutyunova, Elena, Khan, Muhammad Bashir, Fischer, Conrad, Lu, Jimmy, Lamer, Tess, Vuong, Wayne, van Belkum, Marco J., McKay, Ryan T., Tyrrell, D. Lorne, Vederas, John C., Young, Howard S., Lemieux, M. Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061786/
https://www.ncbi.nlm.nih.gov/pubmed/33895266
http://dx.doi.org/10.1016/j.jmb.2021.167003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061786/
https://www.ncbi.nlm.nih.gov/pubmed/33895266
http://dx.doi.org/10.1016/j.jmb.2021.167003

Ejemplares similares